hotspot -WSS

hotspot

author：comprehensive 2025-09-06 02:04:35 - browse：36

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Hospital price transparency does save money, advocate argues

Wikipedia

WSS

Medicare Advantage isn’t working — for anyone

Researchers explore possible ties between long Covid, menopause

Children’s Hospital revives plan for pedestrian bridge

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Researchers explore possible ties between long Covid, menopause

Solve the antibiotic resistance crisis with preventive drugs

explore

hotspot

Sign up for Morning Rounds

leisure time

New air purifier tech could be key to improving indoor air quality

Childhood vaccination ad campaign launches in the U.K.

Apple is now the first public company to be valued at $3 trillion

Are embryos people? Reproductive medicine's future depends on the answer

Psychedelics group wrestles with new pharma identity

STAT Summit: GSK CEO on pharma giant's new direction

Wildfire smoke exposes gaps in outdoor worker protections

Ohio train derailment: Experts on toxic chemical risks

Drug repurposing or repositioning? The language matters

Childhood vaccination ad campaign launches in the U.K.

entertainment

Children’s Hospital revives plan for pedestrian bridge

NIH confirmation hearing shows politicization of research

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Pharmacists can make shortage drugs, but at what cost?

Researchers explore possible ties between long Covid, menopause

CDC panel: People 65 and older should get a Covid spring booster shot

knowledge

Wikipedia

focus

focus